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Translocases: A bacterial tunnel for drugs and proteins
Kim Lewis
Unrelated translocases extrude proteins or
antimicrobial agents across both membranes of the cell
envelope in Gram-negative bacteria. The TolC protein
links the translocases to the external environment. The
recently determined crystal structure of TolC shows
how this universal tunnel operates.
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When the bacterium Escherichia coli needs to move things
out of the cell, whether it is a protein toxin aimed at the
host or an unwanted antibiotic molecule that leaked in,
the outer-membrane protein TolC is often the final portal
in the pathway of transport. A recent paper by Koronakis
and co-authors [1] reports the crystal structure of TolC at
2.1 Å resolution (Figure 1) and suggests how this universal
tunnel operates.
Some pathogenic strains of E. coli that cause urinary tract
infections carry plasmids that code for α-hemolysin, a
protein toxin that inserts into the membrane of host cells,
such as erythrocytes, makes a pore and causes them to lyse.
Apparently, a weakened host makes a better medium in
which E. coli can propagate. Apart from α-hemolysin, the
plasmid codes for the toxin transporter, which is composed
of two different parts. One is a translocase proper, HlyB, a
member of the ‘ATP-binding cassette’ (ABC) transporter
family. The other is a ‘membrane fusion’ protein, HlyD. A
continuous channel forms, apparently by HlyD docking to
the outer-membrane protein TolC. The complex spans
two membranes and the periplasm [2] (Figure 2).
TolC is made of three monomers, which is typical for
many outer membrane porins that form narrow channels
allowing the passage of nutrients into the cell. Like the
porins, the outermost part of TolC that is embedded in
the lipid bilayer of the outer membrane forms a β-barrel
structure, with hydrophobic side chains pointing to the
lipid. Unlike porins, where the narrow channel is formed
by a β-barrel of each monomer [3], each TolC peptide
makes one-third of the wall of a very large, 35 Å inner
diameter cylindrical tunnel. The β-barrel sheet of each
monomer is adjacent to its neighbors, so a continuous
cylinder is formed. The structure of TolC leaves little
doubt about its function — this is a tunnel through which
very large molecules can move.
Bridging the periplasm
After crossing the outer membrane, the TolC cylinder
extends for a further 100 Å into the periplasm. This part of
the structure is geometrically similar to the β-barrel, with
the three monomers forming adjacent sheets, but here of
α-helices, that make up the wall of the tunnel. This novel
protein fold has been named ‘α-helical barrel’. The
chemistry of the periplasmic domain of the molecule is
very different from the outer-membrane part — the
hydrophilic side chains of the α-helices extend into the
periplasm, and into the lumen of the tunnel. Both the
dimensions and the polarity of the α-helical part of the
protein clearly indicate that it resides in an aqueous
environment of the periplasm.
The presence of a large hydrophilic portion of the TolC
tunnel is a fairly unanticipated finding. The role of cross-
ing the periplasm has been so far assigned to the mem-
brane fusion proteins, such as HlyD [4,5]. The structure of
HlyD is not known, but sedimentation and light-scatter-
ing studies of the homologous AcrA component of a mul-
tidrug pump that also docks to TolC suggest a highly
elongated structure with an 8:1 axial ratio [5]. The protein
family that HlyD and AcrA belong to also includes simian
virus 5, a distant, but distinct relative [6]. This viral
protein has a true membrane-fusion function, fusing adja-
cent host cells and allowing the virus to expand. 
All indirect evidence pointed to a minimal model in which
TolC was restricted to the outer membrane (like other
porins), while the elongated membrane fusion protein
linked the membranes (like the simian virus fusion
protein). Now direct evidence shows that this model
needs revision, and the bridge that spans the periplasm is
likely made of two parts — TolC and a membrane fusion
protein. To be precise, the fusion protein is anchored in
the inner membrane, but it actually brings together not
membranes, but proteins — TolC and an inner membrane
translocase. But why is HlyD homologous to the real
membrane fusion protein of simian virus?
If α-hemolysin passes into TolC from the membrane
fusion protein, one can expect that a continuous tunnel is
made by the HlyD–TolC complex. Interestingly, HlyD
forms a trimer [2], which would suggest a seamless link
between the two parts of the tunnel. The dimensions of a
possible HlyD tunnel structure can be estimated on the
bases of what we know about TolC. The design of TolC is
very economical — almost the entire mass of the trimer is
distributed in a sheath that makes up the wall of the
tunnel. The TolC trimer is made of 1413 amino acids that
form a cylinder 140 Å long and about 35 Å in internal
diameter. Given the same length:width:amino acids ratio,
a HlyD trimer of 1437 amino acids has a mass very similar
to the TolC trimer, and could form a cylinder 35 Å in
diameter that is about 140 Å long. This would provide a
very long, 240 Å structure to bridge the periplasm. A
crystal structure of a fusion protein, and of its complex
with TolC, will show whether such a model is realistic.
Given that TolC and a membrane fusion protein need to
bridge the periplasm, it would be nice to know exactly how
wide the space is. There is no consensus on this seemingly
simple matter, perhaps reflecting the shifting nature of the
periplasm. Changes in osmolarity cause expansion/contrac-
tion of the periplasm, so its width will depend on external
conditions. Zones of adhesion, where the outer and inner
membrane form a close contact, have been reported, and it
is possible that proteins such as HlyB–HlyD–TolC are
located in such zones. Might envelope spanning proteins
like HlyB–HlyD–TolC actually form adhesion zones, and
help keep the membranes together? 
The α-hemolysin translocase is only made in some
pathogenic strains of E. coli, so this particular translocase
cannot be essential for adhesion zone formation. Besides,
the HlyB–HlyD–TolC complex is a temporary structure;
only HlyB–HlyD that is bound to α-hemolysin can dock to
TolC [2]. In the absence of α-hemolysin, TolC is free to
associate with other translocases, like the multidrug resis-
tance proteins. Multidrug resistance proteins might form a
more permanent connection to TolC — these proteins are
encoded by chromosomal genes and are present in all
strains of E. coli. In model experiments, an AcrAB complex
was capable of transporting ligands across the membrane of
a proteoliposome [7]. This would suggest that, in vivo, a
more permanent AcrAB–TolC complex ensures that toxic
ligands will not leak into the periplasm.
Whether adhesion zones are permanent structures of the
cell envelope or not, a membrane-bridging location will
subject TolC to stress — variations in osmolarity of the
environment cause the periplasm to expand and contract.
Interestingly, the entire structure of TolC [1] looks like a
combination of two relaxed springs linked by a flexible
joint. The α-helical strands wind around the sides of the
tunnel, and prolines at the junction of the periplasmic and
membrane domains allow for a tilt in the β-barrel in the
opposite direction, forming an angled joint. The α-helical
strands are supercoiled. These different levels of flexibil-
ity might allow the protein to stretch, decreasing the
danger of the complex coming apart.
There is another interesting feature of the protein that
might have evolved in response to the shifting environ-
ment of the periplasm. The end of TolC pointing towards
the periplasm is closed. Koranakis et al. [1] suggest that,
upon interaction with the translocase complex, the coils
closing TolC unwind, forming a large opening into the
tunnel. But why should there be a gate in the first place?
If an expansion of the periplasm tears the complex apart,
an open-ended TolC would make a huge hole in the outer
membrane. This could lead to a rapid penetration of
toxins, including small proteins such as lysozyme, into
the periplasm. But the moment TolC disengages from a
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Figure 1
The architecture of TolC. (a) Structure of the
TolC trimer. Each subunit is shown in a
different color. The subunits are adjacent to
each other, and the overall structure forms a
tunnel. The upper part, 40 Å long, is made of a
β-barrel structure and is located in the outer
membrane. The larger lower part, 100 Å long,
is made of α-helices. (b) A single subunit of
TolC. (c) The topology diagram of a TolC
subunit. A structural repeat coincides with a
repeat in the polypeptide sequence —
apparently the result of gene duplication —
and comprises segments (H1, H2, S1, S2,
H3, H4) and (H5, H6, S4, S5, H7, H8).
(Reproduced, with permission, from [1].)
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membrane fusion protein, the gate will close, preventing
the formation of a dangerous leak.
Evacuating toxic drugs
Why does TolC serve as a channel for both protein toxins
and toxic drugs? Structural biology is much better suited
to addressing the question of ‘how’ than ‘why’. Indeed,
the structure [1] clearly shows that TolC is designed to
accommodate the transport of small molecules as well as
proteins. The coiled coils of the α-helices are kept
together by a ‘knobs-into-holes’ packing of amino-acid
side chains. In this arrangement, small aliphatic side
chains from one helix (knobs) fit into a ring (hole) of four
hydrophobic side chains of the neighboring helix. This
arrangement literally plugs all the holes in the TolC
tunnel through which small molecules might leak. This
ensures that the toxins extruded by the multidrug pumps
do not leak into the periplasm.
One-step transport of antimicrobial agents across the entire
cell envelope provides Gram-negative bacteria with an
enormous drug-resistance capability. Our studies in search
of a mechanism of E. coli resistance to agents that uncouple
oxidative phosphorylation indicated, unexpectedly, that
the responsible protein is a membrane translocase [8]. The
protein, EmrB, is homologous to other translocases of the
‘major facilitator’ family of proteins, which reside in the
inner membrane. This finding was puzzling, as the very
mechanism of uncoupling by compounds such as CCCP
relies on their ability to shuttle back and forth across the
inner membrane carrying protons. One might expect that a
translocase ‘extruding’ CCCP across the inner membrane
would only increase its toxic activity! 
We found that a second protein, EmrA, was encoded by
the same operon as EmrB, and EmrA showed sequence
homology to HlyD. We suggested [8], by analogy to
HlyB–HlyD–TolC, that EmrA–EmrB transports drugs all
the way across the entire cell envelope. This would solve
the apparent ‘uncoupler extrusion’ paradox, as the outer
membrane, unlike the cytoplasmic membrane, is a fairly
good barrier for amphipathic molecules such as CCCP and
other toxins. It was subsequently shown that unrelated
multidrug resistance proteins, such as E. coli AcrAB, are
also associated with a membrane fusion protein homolog
of HlyD, and ‘take advantage’ of the good barrier func-
tions of the outer membrane [9]. 
Variations in extrusion design
In E. coli, unrelated HlyB, EmrB and AcrB are all associated
with homologous membrane fusion proteins, which act as
adaptors that dock these translocases to the same TolC port.
But this arrangement might not be typical — in Pseudomonas
aeruginosa, for example, operons encoding homologs of both
AcrAB and EmrAB also carry genes for TolC homologs, so
these systems do not rely on a universal outer-membrane
portal. It will be interesting to learn whether these
Pseudomonas outer-membrane proteins form wide tunnels,
such as TolC, or rather make narrow channels, suited only
for the passage of drugs. A different example of a narrower
function is provided by a plant pathogen Erwinia chrysan-
themi, which uses Prt proteins related to HlyBD to transport
proteases from the cell, and the translocase operon also
codes for a TolC homolog [10]. In this case, one would
expect a tunnel structure for the TolC homolog to transport
the large proteases, and perhaps a looser wall, not necessar-
ily tightly plugged against leakage of small molecules.
Figure 2
TolC as a universal tunnel. Three different
E. coli translocases use homologous
‘membrane fusion proteins’ to dock to TolC.
This design allows for a transport of
molecules across the entire cell envelope.
HlyB is the translocase of α-hemolysin that is
expressed in some pathogenic strains of
E. coli. HlyB is an ABC-family translocase.
HlyD is the membrane fusion protein. AcrB
belongs to the RND family and is a multidrug
resistance pump that extrudes a wide variety
of antimicrobials, such as β-lactams,
fluoroquinolones, antiseptics and detergents.
The actual point of entry of AcrB substrates
might be the outer bilayer of the inner
membrane. EmrB is a ‘major facilitator’ family
transporter that extrudes uncouplers of
oxidative phosphorylation, a hydrophobic
antibiotic thiolactomycin and nalidixic acid.
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